NCT07267858Active, not recruiting
Clinical Pilates Programme on People With COPD Gold A: a Rehabilitation Nursing Approach.
Effect of a Clinical Pilates Programme on Individuals With Gold A COPD on Lung Function, Motor Performance, Chest Mobility, Sleep and Physical Activity, and Health-related Quality of Life: an Interactive Approach Between Rehabilitation Nursing and Sports Sciences.
Source: ClinicalTrials.gov · Last updated 5 Dec 2025
Brief summary (registry, in English)
The main objective of this study is to evaluate the effects of a Clinical Pilates-based exercise programme on chest mobility, lung function, motor performance, physical activity levels, sleep quality and Health-Related Quality of Life (HRQoL) in individuals with Gold A COPD. Based on our research question, 'What is the effect of a Clinical Pilates programme on thoracic mobility, pulmonary function, motor performance, physical activity levels, sleep quality, and HRQoL in people with Gold A COPD?', we propose the following research hypotheses: H1: The Clinical Pilates programme contributed to improved thoracic mobility in people with Gold A COPD. H2: The Clinical Pilates programme contributed to improved lung function in people with Gold A COPD. H3: The Clinical Pilates programme positively influences the motor performance of people with Gold A COPD. H4: The Clinical Pilates programme positively influences the physical activity levels of people with COPD Gold A. H5: The Clinical Pilates programme positively influences the sleep quality of people with COPD Gold A. H6: The Clinical Pilates programme contributes to improving the HRQoL levels of people with COPD Gold A.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 38 (actual)
- First submitted
- 16 Nov 2025
- Start date
- 7 Nov 2024
- Primary completion date
- 11 Nov 2025
- Lead sponsor
- University of Trás-os-Montes and Alto Douro
- Diseases
- COPD
- NCT number
- NCT07267858
What you commit to
- Study type: Interventional
- Participants enrolled: 38
- From 7 Nov 2024 to the primary completion date, 11 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- People with a history of exacerbation of the disease less than 4 weeks ago, as the guidelines of the European Respiratory Society and the American Thoracic Society (2017) make a conditional recommendation on pulmonary rehabilitation after exacerbation and recommend waiting at least 3 weeks, severe osteoarticular limitation that prevents physical exercise, psychiatric illness or severe cognitive dysfunction, unstable comorbidities such as unstable ischaemic disease or decompensated heart failure, and exercise-induced hypoxemia refractory to oxygen administration.
Who the study is looking for
- Anyone diagnosed with COPD at GOLD stage A, duly identified in SClínico, registered with the USF and residing in the geographical area covered by the Guimarães UCC, whose participation is validated by their family doctor. Inclusion in the study implies participation in at least 60% of the programme sessions, namely 10.
Age in the registry: 40 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Unidade de Cuidados na Comunidade de Guimarães Coordinator of this site? Confirm its status | Guimarães | Portugal | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.